Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program

Achieve Life Sciences (ACHV) Misses Q3 EPS by 15c

November 6, 2019 6:44 AM EST

Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($0.45), $0.15 worse than the analyst estimate of ($0.30).

"It has been a busy and eventful quarter with progressive data analysis further reinforcing the strength of the ORCA-1 Phase 2b trial and the potential for... More